TY - JOUR
T1 - Kikuchi-Fujimoto disease presenting in a patient with SARS-CoV-2
T2 - a case report
AU - Racette, Samuel D.
AU - Alexiev, Borislav A.
AU - Angarone, Michael P.
AU - Bhasin, Ajay
AU - Lima, Kaitlin
AU - Jennings, Lawrence J.
AU - Balasubramanian, Senthil
AU - Matsuoka, Akihiro J.
N1 - Funding Information:
Authors are grateful for contributions and funding from the Department of Otolaryngology and Head and Neck Surgery; Feinberg School of Medicine, Chicago, IL 60611. Funding was provided for the publication fee of the manuscript.
Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12
Y1 - 2021/12
N2 - Background: We present a yet to be described association of SARS-CoV-2 infection with Kikuchi-Fujimoto disease. Case presentation: A 32-year-old physician with history of SARS-CoV-2 infection presented to the emergency department with 2 weeks of fever, chills, and right sided cervical lymphadenopathy. He was treated empirically for presumed folliculitis with worsening of symptoms leading to repeat presentation to the emergency department. Extensive workup was unrevealing of an infectious cause and needle biopsy of the lesion was unrevealing. An excisional lymph node biopsy revealed follicular hyperplasia with necrotic foci showing abundance of histiocytes at the edge of necrosis with CD8 predominance of T-cells. Final diagnosis was deemed to be Kikuchi-Fujimoto disease. Antibiotic therapy was discontinued, and the patient’s symptoms resolved with steroid therapy and expectant management. Conclusions: This is the first report of a patient developing Kikuchi-Fujimoto disease following SARS-CoV-2 infection. Clinicians should be aware of Kikuchi-Fujimoto disease as a possibility when approaching patients with hyper-inflammatory states who present with cervical lymphadenopathy.
AB - Background: We present a yet to be described association of SARS-CoV-2 infection with Kikuchi-Fujimoto disease. Case presentation: A 32-year-old physician with history of SARS-CoV-2 infection presented to the emergency department with 2 weeks of fever, chills, and right sided cervical lymphadenopathy. He was treated empirically for presumed folliculitis with worsening of symptoms leading to repeat presentation to the emergency department. Extensive workup was unrevealing of an infectious cause and needle biopsy of the lesion was unrevealing. An excisional lymph node biopsy revealed follicular hyperplasia with necrotic foci showing abundance of histiocytes at the edge of necrosis with CD8 predominance of T-cells. Final diagnosis was deemed to be Kikuchi-Fujimoto disease. Antibiotic therapy was discontinued, and the patient’s symptoms resolved with steroid therapy and expectant management. Conclusions: This is the first report of a patient developing Kikuchi-Fujimoto disease following SARS-CoV-2 infection. Clinicians should be aware of Kikuchi-Fujimoto disease as a possibility when approaching patients with hyper-inflammatory states who present with cervical lymphadenopathy.
KW - COVID-19
KW - Cervical lymphadenopathy
KW - Kikuchi-Fujimoto Syndrome
KW - SARS-CoV-2
UR - http://www.scopus.com/inward/record.url?scp=85111978309&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111978309&partnerID=8YFLogxK
U2 - 10.1186/s12879-021-06048-0
DO - 10.1186/s12879-021-06048-0
M3 - Article
C2 - 34344305
AN - SCOPUS:85111978309
SN - 1471-2334
VL - 21
JO - BMC Infectious Diseases
JF - BMC Infectious Diseases
IS - 1
M1 - 740
ER -
